# Attovia Therapeutics (ATTO) — Analyst Forecast

ATTO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atto/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 31, 2026 | Morgan Stanley | Initiated Coverage | Overweight | $39.00 |
| Aug 31, 2026 | Citigroup | Initiated Coverage | Buy | $30.00 |
| Aug 31, 2026 | Leerink Partners | Initiated Coverage | Outperform | $52.00 |
| Aug 31, 2026 | LifeSci Capital | Initiated Coverage | Outperform | $45.00 |
| Aug 31, 2026 | RBC Capital | Initiated Coverage | Outperform | $45.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ATTO?

On Aug 31, 2026, Morgan Stanley initiated coverage of Attovia Therapeutics at Overweight with a price target of $39.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).